Harmony Biosciences Holdings, Inc.
US ˙ NasdaqGM ˙ US4131971040

Introduction

This page provides a comprehensive analysis of the known insider trading history of Andreas Wicki. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

See Highest Ranking Insiders
Companies with Reported Insider Positions

The SEC filings indicate Andreas Wicki has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:HRMY / Harmony Biosciences Holdings, Inc. Director 2,147,943
US:PCRX / Pacira BioSciences, Inc. Director 451,324
Director 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Andreas Wicki. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases HRMY / Harmony Biosciences Holdings, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in HRMY / Harmony Biosciences Holdings, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

HRMY / Harmony Biosciences Holdings, Inc. Insider Trades
Insider Sales HRMY / Harmony Biosciences Holdings, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in HRMY / Harmony Biosciences Holdings, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
2022-12-14 HRMY Wicki Andreas 130 60.0000 130 60.0000 7,800 317 19.2000 -5,304 -68.00
2022-12-13 HRMY Wicki Andreas 6,320 60.1300 6,320 60.1300 380,022
2022-12-12 HRMY Wicki Andreas 22,391 60.3600 22,391 60.3600 1,351,521
2022-12-05 HRMY Wicki Andreas 77,853 61.2300 77,853 61.2300 4,766,939
2022-11-15 HRMY Wicki Andreas 10,961 60.1000 10,961 60.1000 658,756
2022-11-14 HRMY Wicki Andreas 40,317 59.1000 40,317 59.1000 2,382,735
2022-11-10 HRMY Wicki Andreas 95,242 58.8000 95,242 58.8000 5,600,230
2022-11-09 HRMY Wicki Andreas 15,301 58.0500 15,301 58.0500 888,223
2022-11-08 HRMY Wicki Andreas 18,865 60.0100 18,865 60.0100 1,132,089
2022-11-04 HRMY Wicki Andreas 157,950 58.8100 157,950 58.8100 9,289,040
2022-11-03 HRMY Wicki Andreas 254,141 59.4400 254,141 59.4400 15,106,141
2022-11-02 HRMY Wicki Andreas 164,676 58.8100 164,676 58.8100 9,684,596
2022-08-10 HRMY Wicki Andreas 71,447 52.6100 71,447 52.6100 3,758,827
2022-08-09 HRMY Wicki Andreas 20,745 53.6700 20,745 53.6700 1,113,384
2022-08-08 HRMY Wicki Andreas 486,360 53.9400 486,360 53.9400 26,234,258
2022-08-05 HRMY Wicki Andreas 29,482 52.5700 29,482 52.5700 1,549,869
2022-08-04 HRMY Wicki Andreas 12,640 52.6700 12,640 52.6700 665,749
2022-08-03 HRMY Wicki Andreas 30,464 52.9000 30,464 52.9000 1,611,546
2022-03-11 HRMY Wicki Andreas 70,370 44.1400 70,370 44.1400 3,106,132
2022-03-10 HRMY Wicki Andreas 75,217 45.8000 75,217 45.8000 3,444,939
2022-03-09 HRMY Wicki Andreas 140,000 45.4900 140,000 45.4900 6,368,600
2022-03-03 HRMY Wicki Andreas 175,000 41.0100 175,000 41.0100 7,176,750
2022-03-02 HRMY Wicki Andreas 328,927 40.5200 328,927 40.5200 13,328,122
2022-03-01 HRMY Wicki Andreas 92,501 40.2400 92,501 40.2400 3,722,240
2021-12-10 HRMY Wicki Andreas 2,585 40.0800 2,585 40.0800 103,607
2021-12-08 HRMY Wicki Andreas 24,683 40.0900 24,683 40.0900 989,541
2021-11-17 HRMY Wicki Andreas 1,417 41.2500 1,417 41.2500 58,451
2021-11-16 HRMY Wicki Andreas 32,251 41.0900 32,251 41.0900 1,325,194
2021-11-15 HRMY Wicki Andreas 35,600 42.0800 35,600 42.0800 1,498,048

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

HRMY / Harmony Biosciences Holdings, Inc. Insider Trades
Insider Purchases PCRX / Pacira BioSciences, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in HRMY / Harmony Biosciences Holdings, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

PCRX / Pacira BioSciences, Inc. Insider Trades
Insider Sales PCRX / Pacira BioSciences, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in HRMY / Harmony Biosciences Holdings, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
2021-03-15 PCRX Wicki Andreas 10,601 73.6800 10,601 73.6800 781,082 207 47.9700 -272,551 -34.89
2021-03-12 PCRX Wicki Andreas 58,754 73.1000 58,754 73.1000 4,294,917
2021-03-11 PCRX Wicki Andreas 60,574 72.7000 60,574 72.7000 4,403,730
2021-03-10 PCRX Wicki Andreas 76,480 71.7800 76,480 71.7800 5,489,734
2021-03-09 PCRX Wicki Andreas 35,137 70.9000 35,137 70.9000 2,491,213
2020-09-09 PCRX Wicki Andreas 2,216 62.0200 2,216 62.0200 137,436
2020-08-13 PCRX Wicki Andreas 34,904 61.4700 34,904 61.4700 2,145,549
2020-08-12 PCRX Wicki Andreas 113,500 60.8200 113,500 60.8200 6,903,070
2020-08-11 PCRX Wicki Andreas 60,621 60.8700 60,621 60.8700 3,690,000
2020-08-11 PCRX Wicki Andreas 46,151 61.9000 46,151 61.9000 2,856,747
2018-12-13 PCRX Wicki Andreas 8,720 46.1803 8,720 46.1803 402,692
2018-12-12 PCRX Wicki Andreas 5,807 47.8394 5,807 47.8394 277,803
2018-11-19 PCRX Wicki Andreas 990 47.0761 990 47.0761 46,605
2018-11-16 PCRX Wicki Andreas 22,100 46.7892 22,100 46.7892 1,034,041
2018-11-16 PCRX Wicki Andreas 3,500 47.0669 3,500 47.0669 164,734
2018-11-15 PCRX Wicki Andreas 26,089 47.6318 26,089 47.6318 1,242,666
2018-11-15 PCRX Wicki Andreas 18,809 47.6445 18,809 47.6445 896,145
2018-11-12 PCRX Wicki Andreas 5,478 49.8321 5,478 49.8321 272,980
2018-11-09 PCRX Wicki Andreas 906 50.2298 906 50.2298 45,508
2018-11-08 PCRX Wicki Andreas 57,339 51.1272 57,339 51.1272 2,931,583
2014-08-29 PCRX Wicki Andreas 10,481 108.1538 10,481 108.1538 1,133,560
2014-08-28 PCRX Wicki Andreas 11,013 108.0629 11,013 108.0629 1,190,097
2014-08-27 PCRX Wicki Andreas 1,606 108.0539 1,606 108.0539 173,535
2014-08-26 PCRX Wicki Andreas 24,207 108.1099 24,207 108.1099 2,617,016
2014-08-25 PCRX Wicki Andreas 30,000 108.0661 30,000 108.0661 3,241,983
2014-08-11 PCRX Wicki Andreas 30,114 101.1959 30,114 101.1959 3,047,413
2014-08-11 PCRX Wicki Andreas 37,786 101.8232 37,786 101.8232 3,847,491
2014-08-08 PCRX Wicki Andreas 82,100 101.0001 82,100 101.0001 8,292,108
2014-06-03 PCRX Wicki Andreas 57,400 80.7179 57,400 80.7179 4,633,207
2014-03-06 PCRX Wicki Andreas 2,200 80.1111 2,200 80.1111 176,244
2014-03-05 PCRX Wicki Andreas 22,687 80.1627 22,687 80.1627 1,818,651
2013-09-11 PCRX Wicki Andreas 2,686 37.2500 2,686 37.2500 100,054
2013-09-11 PCRX Wicki Andreas 15,097 37.2500 15,097 37.2500 562,363
2013-06-12 PCRX Wicki Andreas 4,409 30.0000 4,409 30.0000 132,270
2013-06-11 PCRX Wicki Andreas 9,000 30.0000 9,000 30.0000 270,000
2013-06-10 PCRX Wicki Andreas 2,500 30.0000 2,500 30.0000 75,000
2013-06-05 PCRX Wicki Andreas 2,500 30.0000 2,500 30.0000 75,000
2013-06-04 PCRX Wicki Andreas 13,000 30.3100 13,000 30.3100 394,030
2013-06-03 PCRX Wicki Andreas 1,900 30.0000 1,900 30.0000 57,000

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

PCRX / Pacira BioSciences, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Andreas Wicki as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change		 Share
Price		 Tran
Value		 Remaining
Value
2022-12-14 2022-12-14 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -130 2,147,943 -0.01 60.00 -7,800 128,876,580
2022-12-14 2022-12-13 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -6,320 2,148,073 -0.29 60.13 -380,022 129,163,629
2022-12-14 2022-12-12 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -22,391 2,154,393 -1.03 60.36 -1,351,521 130,039,161
2022-12-07 2022-12-05 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -77,853 2,176,784 -3.45 61.23 -4,766,939 133,284,484
2022-11-16 2022-11-15 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -10,961 2,254,637 -0.48 60.10 -658,756 135,503,684
2022-11-16 2022-11-14 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -40,317 2,265,598 -1.75 59.10 -2,382,735 133,896,842
2022-11-10 2022-11-10 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -95,242 2,305,915 -3.97 58.80 -5,600,230 135,587,802
2022-11-10 2022-11-09 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -15,301 2,401,157 -0.63 58.05 -888,223 139,387,164
2022-11-10 2022-11-08 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -18,865 2,416,458 -0.77 60.01 -1,132,089 145,011,645
2022-11-04 2022-11-04 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -157,950 2,435,323 -6.09 58.81 -9,289,040 143,221,346
2022-11-04 2022-11-03 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -254,141 2,593,273 -8.93 59.44 -15,106,141 154,144,147
2022-11-04 2022-11-02 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -164,676 2,847,414 -5.47 58.81 -9,684,596 167,456,417
2022-08-10 2022-08-10 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -71,447 3,012,090 -2.32 52.61 -3,758,827 158,466,055
2022-08-10 2022-08-09 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -20,745 3,083,537 -0.67 53.67 -1,113,384 165,493,431
2022-08-10 2022-08-08 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -486,360 3,104,282 -13.55 53.94 -26,234,258 167,444,971
2022-08-05 2022-08-05 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -29,482 3,590,642 -0.81 52.57 -1,549,869 188,760,050
2022-08-05 2022-08-04 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -12,640 3,620,124 -0.35 52.67 -665,749 190,671,931
2022-08-05 2022-08-03 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -30,464 3,632,764 -0.83 52.90 -1,611,546 192,173,216
2022-03-11 2022-03-11 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -70,370 3,663,228 -1.88 44.14 -3,106,132 161,694,884
2022-03-11 2022-03-10 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -75,217 3,733,598 -1.97 45.80 -3,444,939 170,998,788
2022-03-11 2022-03-09 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -140,000 3,808,815 -3.55 45.49 -6,368,600 173,262,994
2022-03-04 2022-03-03 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -175,000 3,948,815 -4.24 41.01 -7,176,750 161,940,903
2022-03-04 2022-03-02 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -328,927 4,123,815 -7.39 40.52 -13,328,122 167,096,984
2022-03-04 2022-03-01 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -92,501 4,452,742 -2.04 40.24 -3,722,240 179,178,338
2021-12-10 2021-12-10 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -2,585 4,545,243 -0.06 40.08 -103,607 182,173,339
2021-12-10 2021-12-08 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -24,683 4,547,828 -0.54 40.09 -989,541 182,322,425
2021-11-17 2021-11-17 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -1,417 4,572,511 -0.03 41.25 -58,451 188,616,079
2021-11-17 2021-11-16 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -32,251 4,573,928 -0.70 41.09 -1,325,194 187,942,702
2021-11-17 2021-11-15 4 HRMY Harmony Biosciences Holdings, Inc.
Common Stock 		S - Sale -35,600 4,609,179 -0.77 42.08 -1,498,048 193,954,252
2021-03-16 2021-03-15 4 PCRX Pacira BioSciences, Inc.
Common Stock 		S - Sale -10,601 451,324 -2.29 73.68 -781,082 33,253,552
2021-03-16 2021-03-12 4 PCRX Pacira BioSciences, Inc.
Common Stock 		S - Sale -58,754 461,925 -11.28 73.10 -4,294,917 33,766,718
2021-03-15 2021-03-13 4 VIE Viela Bio, Inc.
Common Stock 		D - Sale to Issuer -1,750,000 0 -100.00 53.00 -92,750,000
2021-03-11 2021-03-11 4 PCRX Pacira BioSciences, Inc.
Common Stock 		S - Sale -60,574 520,679 -10.42 72.70 -4,403,730 37,853,363
2021-03-11 2021-03-10 4 PCRX Pacira BioSciences, Inc.
Common Stock 		S - Sale -76,480 581,253 -11.63 71.78 -5,489,734 41,722,340
2021-03-11 2021-03-09 4 PCRX Pacira BioSciences, Inc.
Common Stock 		S - Sale -35,137 657,733 -5.07 70.90 -2,491,213 46,633,270
2020-09-11 2020-09-09 4 PCRX Pacira BioSciences, Inc.
Common Stock 		S - Sale -2,216 692,970 -0.32 62.02 -137,436 42,977,999
2020-08-13 2020-08-13 4 PCRX Pacira BioSciences, Inc.
Common Stock 		S - Sale -34,904 695,186 -4.78 61.47 -2,145,549 42,733,083
2020-08-13 2020-08-12 4 PCRX Pacira BioSciences, Inc.
Common Stock 		S - Sale -113,500 730,090 -13.45 60.82 -6,903,070 44,404,074
2020-08-13 2020-08-11 4 PCRX Pacira BioSciences, Inc.
Common Stock 		S - Sale -46,151 843,590 -5.19 61.90 -2,856,747 52,218,221
2020-08-13 2020-08-11 4 PCRX Pacira BioSciences, Inc.
Common Stock 		S - Sale -60,621 889,741 -6.38 60.87 -3,690,000 54,158,535
2019-10-09 2019-10-07 4 VIE Viela Bio, Inc.
Series B Preferred Stock 		C - Conversion -1,250,000 0 -100.00
2019-10-09 2019-10-07 4 VIE Viela Bio, Inc.
Common Stock 		P - Purchase 500,000 1,750,000 40.00 19.00 9,500,000 33,250,000
2019-10-09 2019-10-07 4 VIE Viela Bio, Inc.
Common Stock 		C - Conversion 1,250,000 1,250,000
2018-12-14 2018-12-13 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -8,720 950,362 -0.91 46.18 -402,692 43,888,002
2018-12-14 2018-12-12 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -5,807 959,082 -0.60 47.84 -277,803 45,881,907
2018-11-21 2018-11-19 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -990 964,889 -0.10 47.08 -46,605 45,423,211
2018-11-19 2018-11-16 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -3,500 965,879 -0.36 47.07 -164,734 45,460,930
2018-11-19 2018-11-16 4 PCRX Pacira Pharmaceuticals, Inc.
Common stock 		S - Sale -22,100 969,379 -2.23 46.79 -1,034,041 45,356,468
2018-11-19 2018-11-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -18,809 991,479 -1.86 47.64 -896,145 47,238,521
2018-11-19 2018-11-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -26,089 1,010,288 -2.52 47.63 -1,242,666 48,121,836
2018-11-14 2018-11-12 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -5,478 1,036,377 -0.53 49.83 -272,980 51,644,842
2018-11-13 2018-11-09 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -906 1,041,855 -0.09 50.23 -45,508 52,332,168
2018-11-13 2018-11-08 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -57,339 1,042,761 -5.21 51.13 -2,931,583 53,313,450
2014-09-02 2014-08-29 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -10,481 1,100,100 -0.94 108.15 -1,133,560 118,979,995
2014-09-02 2014-08-28 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -11,013 1,110,581 -0.98 108.06 -1,190,097 120,012,604
2014-08-27 2014-08-27 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -1,606 1,121,594 -0.14 108.05 -173,535 121,192,606
2014-08-27 2014-08-26 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -24,207 1,123,200 -2.11 108.11 -2,617,016 121,429,040
2014-08-27 2014-08-25 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -30,000 1,147,407 -2.55 108.07 -3,241,983 123,995,800
2014-08-12 2014-08-11 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -37,786 1,177,407 -3.11 101.82 -3,847,491 119,887,348
2014-08-12 2014-08-11 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -30,114 1,215,193 -2.42 101.20 -3,047,413 122,972,549
2014-08-12 2014-08-08 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -82,100 1,245,307 -6.18 101.00 -8,292,108 125,776,132
2014-06-11 2014-06-09 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -9,289 1,327,407 -0.69 86.43 -802,882 114,732,566
2014-06-11 2014-06-09 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -33,653 1,336,696 -2.46 85.81 -2,887,680 114,698,542
2014-06-11 2014-06-09 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -25,058 1,370,349 -1.80 84.55 -2,118,624 115,861,364
2014-06-06 2014-06-06 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -40,200 1,395,407 -2.80 82.71 -3,324,753 115,407,555
2014-06-06 2014-06-05 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -23,200 1,435,607 -1.59 82.53 -1,914,668 118,478,923
2014-06-06 2014-06-04 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -4,500 1,458,807 -0.31 82.40 -370,809 120,208,469
2014-06-03 2014-06-03 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -57,400 1,463,307 -3.77 80.72 -4,633,207 118,115,068
2014-06-03 2014-06-02 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -10,600 1,520,707 -0.69 80.52 -853,498 122,445,351
2014-05-28 2014-05-27 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -64,400 1,531,307 -4.04 77.93 -5,018,750 119,336,133
2014-05-22 2014-05-21 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -3,600 1,595,707 -0.23 77.80 -280,086 124,148,717
2014-05-12 2014-05-08 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -23,220 1,599,307 -1.43 75.76 -1,759,215 121,168,136
2014-05-07 2014-05-07 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -600 1,622,527 -0.04 75.64 -45,386 122,731,999
2014-05-07 2014-05-06 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -44,180 1,623,127 -2.65 75.78 -3,348,062 123,004,297
2014-03-06 2014-03-06 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -2,200 1,667,307 -0.13 80.11 -176,244 133,569,798
2014-03-06 2014-03-05 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -22,687 1,669,507 -1.34 80.16 -1,818,651 133,832,189
2013-09-12 2013-09-11 4 PCRX Pacira Pharmaceuticals, Inc.
Warrant (right to buy) 		X - Other -41,841 0 -100.00
2013-09-12 2013-09-11 4 PCRX Pacira Pharmaceuticals, Inc.
Warrant (right to buy) 		X - Other -37,192 0 -100.00
2013-09-12 2013-09-11 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -15,097 1,692,194 -0.88 37.25 -562,363 63,034,226
2013-09-12 2013-09-11 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		X - Other 41,841 1,707,291 2.51 13.44 562,343 22,945,991
2013-09-12 2013-09-11 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -2,686 1,665,450 -0.16 37.25 -100,054 62,038,012
2013-09-12 2013-09-11 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		X - Other 37,192 1,668,136 2.28 2.69 100,046 4,487,286
2013-07-23 2013-07-22 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -19,938 1,630,944 -1.21 35.28 -703,508 57,547,533
2013-07-23 2013-07-19 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -56,020 1,650,882 -3.28 34.98 -1,959,524 57,746,201
2013-07-19 2013-07-18 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -4,042 1,706,902 -0.24 34.80 -140,662 59,400,190
2013-07-19 2013-07-17 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -21,518 1,710,944 -1.24 33.20 -714,398 56,803,341
2013-07-17 2013-07-16 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -350 1,732,462 -0.02 33.20 -11,620 57,517,738
2013-07-17 2013-07-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -48,132 1,732,812 -2.70 33.28 -1,601,833 57,667,983
2013-07-15 2013-07-11 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -80,000 1,780,944 -4.30 31.48 -2,518,416 56,064,473
2013-07-09 2013-07-05 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -44,021 1,860,944 -2.31 30.80 -1,355,961 57,321,914
2013-07-03 2013-07-03 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -50,000 1,904,965 -2.56 30.67 -1,533,300 58,417,657
2013-07-03 2013-07-02 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -60,597 1,954,965 -3.01 29.85 -1,808,820 58,355,705
2013-07-03 2013-07-01 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -3,851 2,015,562 -0.19 29.85 -114,952 60,164,526
2013-06-21 2013-06-19 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -35,407 2,019,413 -1.72 29.90 -1,058,726 60,383,680
2013-06-19 2013-06-17 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -50,145 2,054,820 -2.38 29.86 -1,497,224 61,352,610
2013-06-14 2013-06-12 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -4,409 2,104,965 -0.21 30.00 -132,270 63,148,950
2013-06-12 2013-06-11 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -9,000 2,109,374 -0.42 30.00 -270,000 63,281,220
2013-06-12 2013-06-10 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -2,500 2,118,374 -0.12 30.00 -75,000 63,551,220
2013-06-06 2013-06-05 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -2,500 2,120,874 -0.12 30.00 -75,000 63,626,220
2013-06-06 2013-06-04 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -13,000 2,123,374 -0.61 30.31 -394,030 64,359,466
2013-06-05 2013-06-03 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -1,900 2,136,374 -0.09 30.00 -57,000 64,091,220
2013-05-31 2013-05-31 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -3,033 2,138,274 -0.14 30.00 -90,990 64,148,220
2013-05-31 2013-05-30 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -2,500 2,141,307 -0.12 30.00 -75,000 64,239,210
2013-05-24 2013-05-22 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -18,471 2,143,807 -0.85 30.00 -554,130 64,314,210
2013-05-22 2013-05-20 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -14,374 2,162,278 -0.66 30.00 -431,220 64,868,340
2013-04-25 2013-04-24 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -401 2,176,652 -0.02 30.04 -12,045 65,380,967
2013-04-25 2013-04-23 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -15,646 2,177,053 -0.71 30.00 -469,380 65,311,590
2013-04-17 2013-04-15 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -6,400 2,192,699 -0.29 30.00 -192,020 65,787,987
2013-04-15 2013-04-12 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -34,294 2,199,099 -1.54 30.00 -1,028,820 65,972,970
2013-04-15 2013-04-11 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -600 2,233,393 -0.03 30.00 -18,000 67,001,790
2013-03-25 2013-03-25 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -165,541 2,233,993 -6.90 28.28 -4,680,738 63,167,046
2013-03-25 2013-03-22 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -113,928 2,399,534 -4.53 27.52 -3,135,595 66,041,414
2013-03-25 2013-03-21 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -11,431 2,513,462 -0.45 27.50 -314,352 69,120,205
2013-03-21 2013-03-19 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -9,100 2,524,893 -0.36 27.86 -253,501 70,336,449
2013-03-21 2013-03-18 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale X -400,000 2,533,993 -13.63 28.19 -11,277,480 71,442,638
2013-03-21 2013-03-11 4 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		S - Sale -500,000 2,933,993 -14.56 27.86 -13,930,000 81,741,045
2011-02-02 3 PCRX Pacira Pharmaceuticals, Inc.
Common Stock 		92,980
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)